The promising medication, this new drug, is generating significant buzz in the country for a new option for weight management. Created by Eli Lilly, this medicine merges the effects of different glucagon-like peptide-1 (GLP-1) receptor agonists and an GIP receptor agonist, seeking to better contr… Read More